<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:npr="https://www.npr.org/rss/" xmlns:nprml="https://api.npr.org/nprml" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:media="http://search.yahoo.com/mrss/" version="2.0">
  <channel>
    <title>NPR: Johnson &amp; Johnson</title>
    <link>https://www.npr.org/templates/story/story.php?storyId=147037949</link>
    <description>Johnson &amp; Johnson</description>
    <language>en</language>
    <copyright>Copyright 2024 NPR - For Personal Use Only</copyright>
    <generator>Story API Shim 1.2.24</generator>
    <lastBuildDate>Wed, 07 May 2025 00:27:37 -0400</lastBuildDate>
    <image>
      <url>https://media.npr.org/images/podcasts/primary/npr_generic_image_300.jpg?s=200</url>
      <title>NPR: Johnson &amp; Johnson</title>
      <link>https://www.npr.org/tags/147037949/johnson-johnson</link>
    </image>
    <item>
      <title>Moderna&apos;s COVID vaccine gambit: Hike the price, offer free doses for uninsured</title>
      <description>Once U.S. stockpiles of COVID-19 vaccine run out, Moderna says it might charge as much as $130 per dose, but give people who lack health insurance a break. Critics say that&apos;s not enough help.</description>
      <pubDate>Wed, 08 Mar 2023 05:01:12 -0500</pubDate>
      <link>https://www.npr.org/sections/health-shots/2023/03/08/1161353892/modernas-covid-vaccine-gambit-hike-the-price-offer-free-doses-for-uninsured</link>
      <guid>https://www.npr.org/sections/health-shots/2023/03/08/1161353892/modernas-covid-vaccine-gambit-hike-the-price-offer-free-doses-for-uninsured</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2023/03/06/gettyimages-1243776587-0fc51040ae6efafc17613f6feafc736f2e478392.jpg' alt='A vial of the Moderna's COVID-19 vaccine, Bivalent. Though the shots are free to pretty much anyone who wants one in the U.S. as long as federal stockpiles hold out, the next update of the vaccine might be costly for some people who lack health insurance.'/><p>Once U.S. stockpiles of COVID-19 vaccine run out, Moderna says it might charge as much as $130 per dose, but give people who lack health insurance a break. Critics say that's not enough help.</p><p>(Image credit: RINGO CHIU)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=1161353892' />]]></content:encoded>
      <dc:creator>Sydney Lupkin</dc:creator>
    </item>
    <item>
      <title>Appeals court clears the way for more lawsuits over Johnson&apos;s Baby Powder</title>
      <description>A U.S. appeals court has dismissed the bankruptcy case filed by a Johnson &amp; Johnson spinoff company. Around 40,000 cancer patients have filed suit, alleging the powder was contaminated with asbestos.</description>
      <pubDate>Mon, 30 Jan 2023 16:32:19 -0500</pubDate>
      <link>https://www.npr.org/2023/01/30/1152600293/appeals-court-clears-the-way-for-more-lawsuits-over-johnsons-baby-powder</link>
      <guid>https://www.npr.org/2023/01/30/1152600293/appeals-court-clears-the-way-for-more-lawsuits-over-johnsons-baby-powder</guid>
      <content:encoded><![CDATA[<p>A U.S. appeals court has dismissed the bankruptcy case filed by a Johnson & Johnson spinoff company. Around 40,000 cancer patients have filed suit, alleging the powder was contaminated with asbestos.</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=1152600293' />]]></content:encoded>
      <dc:creator>Scott Horsley</dc:creator>
    </item>
    <item>
      <title>J&amp;J tried to block lawsuits from 40,000 cancer patients. A court wants answers</title>
      <description>Critics say a legal maneuver by one of the world&apos;s wealthiest corporations could set a precedent, allowing non-bankrupt companies and rich individuals to avoid liability for wrongdoing.</description>
      <pubDate>Mon, 19 Sep 2022 17:46:03 -0400</pubDate>
      <link>https://www.npr.org/2022/09/19/1123567606/johnson-baby-powder-bankruptcy-lawsuits</link>
      <guid>https://www.npr.org/2022/09/19/1123567606/johnson-baby-powder-bankruptcy-lawsuits</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2022/09/19/gettyimages-998003060_slide-354db5bff9f17bd324f2e711290aa634ba8dbfe8.jpg' alt='A bottle of Johnson & Johnson baby powder is displayed on a table. J&J pulled its iconic Johnson's baby powder off the shelves in the U.S. in 2020.'/><p>Critics say a legal maneuver by one of the world's wealthiest corporations could set a precedent, allowing non-bankrupt companies and rich individuals to avoid liability for wrongdoing.</p><p>(Image credit: Justin Sullivan)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=1123567606' />]]></content:encoded>
      <dc:creator>Brian Mann</dc:creator>
    </item>
    <item>
      <title>Idaho announces $119 million opioid crisis settlement</title>
      <description>Idaho Gov. Brad Little and Attorney General Lawrence Wasden say it&apos;s the second-largest consumer settlement in state history.</description>
      <pubDate>Fri, 13 May 2022 21:27:29 -0400</pubDate>
      <link>https://www.npr.org/2022/05/13/1098933454/idaho-announces-119-million-opioid-crisis-settlement</link>
      <guid>https://www.npr.org/2022/05/13/1098933454/idaho-announces-119-million-opioid-crisis-settlement</guid>
      <content:encoded><![CDATA[<p>Idaho Gov. Brad Little and Attorney General Lawrence Wasden say it's the second-largest consumer settlement in state history.</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=1098933454' />]]></content:encoded>
      <dc:creator>The Associated Press</dc:creator>
    </item>
    <item>
      <title>Rich companies are using a quiet tactic to block lawsuits: bankruptcy</title>
      <description>Companies that aren&apos;t bankrupt are using controversial maneuvers in U.S. bankruptcy court to block tens of thousands of suits. A woman suing Johnson &amp; Johnson died while her case was in legal limbo.</description>
      <pubDate>Sat, 02 Apr 2022 07:00:47 -0400</pubDate>
      <link>https://www.npr.org/2022/04/02/1082871843/rich-companies-are-using-a-quiet-tactic-to-block-lawsuits-bankruptcy</link>
      <guid>https://www.npr.org/2022/04/02/1082871843/rich-companies-are-using-a-quiet-tactic-to-block-lawsuits-bankruptcy</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2022/02/25/jmm-hannawilt-43_custom-321d6cddd6325856c81afcbc70b82568c3cb1315.jpg' alt='Hope Schiller Wilt (left) and her daughter, Hanna Wilt, outside her home on Nov. 19, 2021, in Manasquan, N.J. The family plans to continue her lawsuit. "It's what she wanted," her mother said.'/><p>Companies that aren't bankrupt are using controversial maneuvers in U.S. bankruptcy court to block tens of thousands of suits. A woman suing Johnson & Johnson died while her case was in legal limbo.</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=1082871843' />]]></content:encoded>
      <dc:creator>Brian Mann</dc:creator>
    </item>
    <item>
      <title>Johnson &amp; Johnson wins a key court battle in baby powder case</title>
      <description>A federal judge has allowed a Johnson &amp; Johnson spinoff to proceed with a controversial bankruptcy, despite complaints from thousands who say they were harmed by the company&apos;s baby powder.</description>
      <pubDate>Fri, 25 Feb 2022 13:23:27 -0500</pubDate>
      <link>https://www.npr.org/2022/02/25/1083061992/johnson-johnson-wins-court-battle-bankruptcy-baby-powder</link>
      <guid>https://www.npr.org/2022/02/25/1083061992/johnson-johnson-wins-court-battle-bankruptcy-baby-powder</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2022/02/25/gettyimages-1352916404-3970747c1c58396ef4c7c5f76701f860e06461f3.jpg' alt='Johnson & Johnson's baby powder is displayed on a table in this photo illustration. A federal judge has allowed Johnson & Johnson's spinoff of a unit to proceed with a controversial bankruptcy.'/><p>A federal judge has allowed a Johnson & Johnson spinoff to proceed with a controversial bankruptcy, despite complaints from thousands who say they were harmed by the company's baby powder.</p><p>(Image credit: Justin Sullivan)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=1083061992' />]]></content:encoded>
      <dc:creator>Scott Horsley</dc:creator>
    </item>
    <item>
      <title>J&amp;J tries the &apos;Texas Two-Step&apos;</title>
      <description>For years, Johnson &amp; Johnson has been entangled in lawsuits regarding its talcum based products being linked to causing ovarian cancer. And to save itself from future lawsuits, the company is betting big on a tricky legal move named after a famous dance.</description>
      <pubDate>Wed, 05 Jan 2022 18:24:31 -0500</pubDate>
      <link>https://www.npr.org/2022/01/05/1070765481/j-j-tries-the-texas-two-step</link>
      <guid>https://www.npr.org/2022/01/05/1070765481/j-j-tries-the-texas-two-step</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2022/01/05/gettyimages-1352916405-79029f0fd3f3b4473fde791ecf65d23e94c19e9f.jpg' alt='undefined'/><p>For years, Johnson & Johnson has been entangled in lawsuits regarding its talcum based products being linked to causing ovarian cancer. And to save itself from future lawsuits, the company is betting big on a tricky legal move named after a famous dance.</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=1070765481' />]]></content:encoded>
      <dc:creator>Stacey Vanek Smith</dc:creator>
    </item>
    <item>
      <title>Coronavirus FAQ: I just got a booster. Can I go back to my pre-pandemic routines?</title>
      <description>Does a booster shot mean that you can return to your old normal? Or is there still a newish kind of normal to face?</description>
      <pubDate>Fri, 12 Nov 2021 16:02:00 -0500</pubDate>
      <link>https://www.npr.org/sections/goatsandsoda/2021/11/12/1055145678/coronavirus-faq-i-just-got-a-booster-can-i-go-crazy</link>
      <guid>https://www.npr.org/sections/goatsandsoda/2021/11/12/1055145678/coronavirus-faq-i-just-got-a-booster-can-i-go-crazy</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2021/11/12/faq-booster-1-66db6648eff21968bca4c5d7dea7ca6fd0ffa7c6.jpg' alt='Nurse Sandra Lindsay celebrates after receiving her COVID-19 Pfizer vaccine booster at Long Island Jewish Medical Center in New York in October. Lindsay was the first person known to receive a COVID vaccine in the United States vaccination campaign — on Dec. 14, 2020. Her vaccination card is displayed at the COVID-19 exhibit in the Smithsonian Museum of American History.'/><p>Does a booster shot mean that you can return to your old normal? Or is there still a newish kind of normal to face?</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=1055145678' />]]></content:encoded>
      <dc:creator>Sheila Mulrooney Eldred</dc:creator>
    </item>
    <item>
      <title>FDA authorizes use of Pfizer&apos;s COVID vaccine for 5- to 11-year-olds</title>
      <description>The agency acted after an independent panel of scientists strongly supported the move. Kids could start getting vaccinated within the week.</description>
      <pubDate>Fri, 29 Oct 2021 15:21:20 -0400</pubDate>
      <link>https://www.npr.org/sections/health-shots/2021/10/29/1049704374/fda-authorizes-use-of-pfizers-covid-vaccine-for-5-to-11-year-olds</link>
      <guid>https://www.npr.org/sections/health-shots/2021/10/29/1049704374/fda-authorizes-use-of-pfizers-covid-vaccine-for-5-to-11-year-olds</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2021/10/27/gettyimages-1232868037-49461ac1b077cabf901e55c581b19152c31770db.jpg' alt='Ari Blank got a comforting hand-squeeze from his mom in May as he was vaccinated against COVID-19 in Bloomfield Hills, Mich. This week, the Food and Drug Administration authorized the use of Pfizer's vaccine in even younger kids — ages 5 to 11.'/><p>The agency acted after an independent panel of scientists strongly supported the move. Kids could start getting vaccinated within the week.</p><p>(Image credit: Jeff Kowalsky)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=1049704374' />]]></content:encoded>
      <dc:creator>Joe Neel</dc:creator>
    </item>
    <item>
      <title>CDC backs the rollout of COVID vaccine boosters from Moderna and J&amp;J</title>
      <description>CDC Director Rochelle Walensky also endorsed a mix-and-match approach to boosters that would be flexible for patients and health care providers.</description>
      <pubDate>Thu, 21 Oct 2021 17:28:38 -0400</pubDate>
      <link>https://www.npr.org/sections/health-shots/2021/10/21/1048056560/cdc-advisers-back-rollout-of-covid-vaccine-boosters-from-moderna-and-j-j</link>
      <guid>https://www.npr.org/sections/health-shots/2021/10/21/1048056560/cdc-advisers-back-rollout-of-covid-vaccine-boosters-from-moderna-and-j-j</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2021/10/21/ny_vax_gettyimages-1347922554-f72f4a8cc88d2f106e8984515ea14155b5123b13.jpg' alt='A health care worker administers a Pfizer-BioNTech COVID-19 vaccine Thursday at Life of Hope Center in New York City.'/><p>CDC Director Rochelle Walensky also endorsed a mix-and-match approach to boosters that would be flexible for patients and health care providers.</p><p>(Image credit: Michael M. Santiago)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=1048056560' />]]></content:encoded>
      <dc:creator>Scott Hensley</dc:creator>
    </item>
  </channel>
</rss>